Intuitive Surgical, Inc. $ISRG Shares Sold by Arizona State Retirement System

Key Points

• Arizona State Retirement System trimmed its stake in Intuitive Surgical by 2.7% in Q4, selling 2,803 shares and leaving it with 101,868 shares valued at $57.694 million; institutional investors own about 83.64% of the stock.
• Q1 beat: Intuitive reported EPS of $2.50 versus $2.08 expected and revenue of $2.77 billion (up 23% year‑over‑year), driving analyst bullishness and a raised outlook despite near‑term volatility.
• Insider selling and headwinds: Insiders sold 32,943 shares (~$17.28M) over the past three months, and mixed analyst price‑target cuts plus a disclosed contained cyber incident have added short‑term uncertainty.

Arizona State Retirement System trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 101,868 shares of the medical equipment provider's stock after selling 2,803 shares during the period. Arizona State Retirement System's holdings in Intuitive Surgical were worth $57,694,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in ISRG. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth $25,000. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after buying an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter worth approximately $27,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

ISRG stock opened at $478.82 on Friday. The company has a fifty day moving average price of $477.54 and a 200 day moving average price of $515.16. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The company has a market cap of $170.04 billion, a price-to-earnings ratio of 58.04, a price-to-earnings-growth ratio of 3.78 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical's revenue for the quarter was up 23.0% on a year-over-year basis. During the same period last year, the firm posted $1.81 EPS. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 8.16 earnings per share for the current year.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and raised outlook — ISRG reported stronger‑than‑expected Q1 revenue and EPS, raised full‑year procedure guidance and cited broad procedure adoption; that drove the initial rally after the print. Read More.
• Positive Sentiment: da Vinci 5 and innovation-led revenue — Analysts and coverage note revenues are outpacing procedures as da Vinci 5 placements and service/consumable pricing power shift growth toward innovation and value-based revenue. Read More.
• Positive Sentiment: Analysts reaffirm bullish views — several firms reiterated buy/overweight ratings and raised forecasts after the quarter, saying procedure momentum and platform adoption support longer‑term upside. Read More.
• Neutral Sentiment: Market commentary highlights long‑term case — investment pieces argue ISRG remains a secular winner in robotic surgery despite near‑term volatility; these are thematic views rather than short‑term catalysts. Read More.
• Negative Sentiment: Mixed/trimmed price targets — several banks trimmed price targets post‑earnings (some materially) even while keeping buy/overweight ratings; the patchwork of cuts likely contributed to selling pressure. Read More.
• Negative Sentiment: Cybersecurity note — the company disclosed a contained cyber incident and is remediating; while management calls it contained, such disclosures can increase near‑term uncertainty for investors. Read More.
• Negative Sentiment: Guidance conservatism / profit‑taking — some coverage points out the company raised guidance modestly relative to the beat, which may signal conservative assumptions and prompted traders to book gains after the initial surge. Read More.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,943 shares of company stock worth $17,279,568 over the last three months. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on ISRG. Zacks Research lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 30th. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an "overweight" rating in a report on Thursday. Truist Financial reduced their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating for the company in a research report on Wednesday, April 15th. UBS Group lowered their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating for the company in a report on Tuesday, March 17th. Finally, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $581.91.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.